Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza A/B Assay in Nasal Samples

[1] Pormohammad A(2021)Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials Vaccines (Basel). 9 467-426

[2] Zarei M(2021)Testing at scale during the COVID-19 pandemic Nat Rev Genet 22 415-583

[3] Ghorbani S(2021)Clinical performance of the point-of-Care cobas Liat for detection of SARS-CoV-2 in 20 minutes: a multicenter study J Clin Microbiol 59 e02811-20-291

[4] Mohammadi M(2019)Analytical and clinical evaluation of a point-of-care molecular diagnostic system and its influenza A/B assay for rapid molecular detection of the influenza virus J Infect Chemother 25 578-e419

[5] Razizadeh MH(2019)In-house validation of the cobas Liat influenza A/B and RSV assay for use with gargles, sputa and endotracheal secretions J Hosp Infect 101 289-1134

[6] Turner DL(2019)Evaluation of the Liat Cdiff assay for direct detection of clostridioides difficile toxin genes within 20 minutes J Clin Microbiol 57 e00416-504

[7] Mercer TR(2017)Accurate detection of streptococcus pyogenes at the point of care using the cobas Liat Strep A nucleic acid test Clin Pediatr (Phila) 56 1128-e920

[8] Salit M(2021)Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study Sci Rep 11 10519-307

[9] Hansen G(2021)A prospective evaluation of the analytical performance of GENECUBE Mol Diagn Ther 25 495-e3020

[10] Marino J(2020) HQ SARS-CoV-2 and GENECUBE N Engl J Med 382 e76-1026

[1] Pormohammad A(2021)Efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis of randomized clinical trials Vaccines (Basel). 9 467-426

[2] Zarei M(2021)Testing at scale during the COVID-19 pandemic Nat Rev Genet 22 415-583

[3] Ghorbani S(2021)Clinical performance of the point-of-Care cobas Liat for detection of SARS-CoV-2 in 20 minutes: a multicenter study J Clin Microbiol 59 e02811-20-291

[4] Mohammadi M(2019)Analytical and clinical evaluation of a point-of-care molecular diagnostic system and its influenza A/B assay for rapid molecular detection of the influenza virus J Infect Chemother 25 578-e419

[5] Razizadeh MH(2019)In-house validation of the cobas Liat influenza A/B and RSV assay for use with gargles, sputa and endotracheal secretions J Hosp Infect 101 289-1134

[6] Turner DL(2019)Evaluation of the Liat Cdiff assay for direct detection of clostridioides difficile toxin genes within 20 minutes J Clin Microbiol 57 e00416-504

[7] Mercer TR(2017)Accurate detection of streptococcus pyogenes at the point of care using the cobas Liat Strep A nucleic acid test Clin Pediatr (Phila) 56 1128-e920

[8] Salit M(2021)Diagnostic performance and characteristics of anterior nasal collection for the SARS-CoV-2 antigen test: a prospective study Sci Rep 11 10519-307

[9] Hansen G(2021)A prospective evaluation of the analytical performance of GENECUBE Mol Diagn Ther 25 495-e3020

[10] Marino J(2020) HQ SARS-CoV-2 and GENECUBE N Engl J Med 382 e76-1026